The American Academy of Neurology (AAN) Annual Meeting brings together an international attendance of the neurology committee to promote the highest quality patient-centered neurologic care, convey the latest advances, and enhance career satisfaction.
Improving Device-Aided Therapy Screening in Parkinson Disease: Hubert Fernandez, MDMay 15th 2021
The director of the Center for Neurological Restoration at Cleveland Clinic discussed why gaps remain in screening for patients with Parkinson disease who may be eligible for device-aided therapies.
Leaving a Nebulous State of Care for Patients With NMOSD: Bruce Cree, MD, PhDMay 11th 2021
The clinical research director at the UCSF Multiple Sclerosis Center shared some of the takeaways from his research for the clinical community of specialists treating patients with NMOSD.
Better Defining Multiple Sclerosis Categorization: Daniel Ontaneda, MD, PhDMay 11th 2021
The associate professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University discussed the potential of a data-driven approach to classifying patients with MS.
Clinical Utility of Manual Dexterity Test in MS: Marisa McGinley, DOMay 10th 2021
The staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic discussed how novel dexterity measurements can improve prognostication of disease progression.
Gaps in Access to Device-Aided Therapies for Parkinson Disease: Hubert Fernandez, MDMay 6th 2021
The director of the Center for Neurological Restoration at Cleveland Clinic spoke to how identifying care gaps in Parkinson disease patients is not a niche issue, but part of a bigger problem.
Nipocalimab in Myasthenia Gravis and the Remaining Needs for PatientsMay 6th 2021
Jeffrey Guptill, MD, MS, MHS, associate professor of neurology at neurologist at Duke University, detailed early positive results for nipocalimab in myasthenia gravis and the urgency to provide more treatment options for patients.
Data-Driven Categorization of Patients With Multiple Sclerosis: Daniel Ontaneda, MD, PhDMay 5th 2021
The associate professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University discussed the findings of his presentation at AAN 2021.
NeuroVoices: Vineet Punia, MD, MS, on Responsive Neurostimulation in Older AdultsMay 5th 2021
The neurologist from Cleveland Clinic discussed his study presented at AAN 2021 involving the use of responsive neurostimulation in older adults with drug-resistant focal epilepsy and further expanding research in this space.
Advantages of Atogepant in Ever-Growing CGRP Market: Lawrence Severt, MD, PhDMay 4th 2021
The director at AbbVie highlighted where atogepant stands among the increasing treatment landscape of anti-calcitonin gene-related peptide options within the migraine treatment landscape.